Search Results 2541-2550 of 18168 for rheumatoid arthritis

  1. Publications - Luca Stocchi, M.D. - Mayo Clinic

    ... factor agents in postoperative recurrent Crohn's disease following ileocolonic resection. Int J Colorectal Dis. 2016 Nov; 31 (11):1751-1758 Epub 2016 July ...

  2. Screening for High Frequency Malignant Disease - Mayo Clinic

    Currently taking any anti-neoplastic or disease-modifying anti-rheumatic drugs (DMARDs). Currently receiving treatment for pneumonia. Any major physical ...

  3. A Study to Assess Older Adults Applying Pre-transplant Comorbidity, Geriatric Assessment and Biomarkers to Predict Non-Relapse Mortality After Allogeneic Transplant (CHARM) - Mayo Clinic

    ... factor guiding treatment decisions in oncology. By contrast, a geriatric assessment can provide a much more comprehensive understanding of the functional ...

  4. Publications - Martha-Gracia Knuttinen, M.D., Ph.D. - Mayo Clinic

    Knuttinen MG, Jajko R, Scoccia B. Fluoroscopic tubal recanalization in tubal factor related infertility. Semin Intervent Radiol. 2014 Sep; 31(3):269-71. View ...

  5. A Study to Evaluate the Effectiveness and Safety of Triple Combination Therapy in High Risk Crohn's Disease (CD) - Mayo Clinic

    The purpose of this study is to determine the effect of triple combination therapy with an anti-integrin (vedolizumab intravenous [IV]), a tumor necrosis factor ...

  6. Publications - Steven Attia, D.O. - Mayo Clinic

    ... Factor Pathway in Angiosarcoma. Front Oncol. 2018; 8:71 Epub 2018 Mar 22. View PubMed; Bagaria SP, Chang YH, Gray RJ, Ashman JB, Attia S, Wasif N. Improving ...

  7. Hematology - Clinical trials

    The purpose of this study is to learn about how platelets adhere to the blood von Willebrand factor and how known clinical mutations that result in bleeding ...

  8. Publications - Christian Hanna, M.D., M.S. - Mayo Clinic

    Hypoxia-inducible factor-2alpha and TGF-beta signaling interact to promote normoxic glomerular fibrogenesis. Am J Physiol Renal Physiol. 2013 Nov 1; 305 (9): ...

  9. Non Clinical Trials - Mayo Clinic Research

    ... factor receptor (EGFR) activating mutations. This study will also assess overall survival, overall response rate, progression free survival assessed by the ...

  10. Metastatic Prostate Cancer Clinical Trials - Mayo Clinic Research

    Pertuzumab and trastuzumab are monoclonal antibodies and forms of targeted therapy that attach to a receptor protein called human epidermal growth factor ...